Abbott Laboratories (ABT) 41.78 $ABT
Watch for Abbott Laboratories to Potentially Rebound After Falling 1.44% Yesterday
Comtex SmarTrend(R) - Tue Aug 05, 5:33PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $41.66 to a high of $42.37. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $41.81 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Roche to Acquire Santaris Pharma to Expand RNA Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 4:45PM CDT
In a bid to expand the discovery and development of RNA-targeting medicines, Roche (RHHBY) announced that it has entered into an agreement to acquire Denmark-based privately-held biopharmaceutical company Santaris Pharma.
India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019
M2 - Tue Aug 05, 5:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n5h8m7/india_patient) has announced the addition of the "India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for India Patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 Indian Market for Patient Monitoring and Diagnostics (2006-2019) 5 Indian Market for Blood Pressure Monitors (2006-2019) 6 Indian Market for Cardiovascular Monitoring Systems (2006-2019) 7 Indian Market for Blood Glucose Monitoring Devices (2006-2019) 8 Indian Market for Hearing Diagnostics (2006-2019) 9 Indian Market for Micro-Electromechanical Systems(2006-2019) 10 Indian Market for Multiparameter Patient Monitors (2006-2019) 11 Indian Market for Remote Monitoring Systems (2006-2019) 12 Indian Market for Sleep Apnea Diagnostic Systems (2006-2019) 13 Indian Market for Wireless Hospital Ambulatory Monitors (2006-2019) 14 Recent Events and Developments 15 Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/n5...ia_patient
India Sleep Apnea Diagnostic Systems Market, 2006 - 2019
M2 - Tue Aug 05, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/whn3h9/india_sleep_apnea) has announced the addition of the "India Sleep Apnea Diagnostic Systems Market, 2006 - 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in India through 2019. The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. - Average selling price ($) for each product type (2006 to 2019). - Recent Events and Developments Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Key Topics Covered: 1 Table of Contents 2. Introduction 3. Scope of the Report 4. Indian Market for Sleep Apnea Diagnostic Systems, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/wh...leep_apnea
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Business Wire - Mon Aug 04, 5:30AM CDT
RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women's health, announced today the appointment of Mark Weinberg MD, MBA as Senior Vice President of Clinical Development.
Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche
M2 - Fri Aug 01, 5:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lvvzs3/global_medical) has announced the addition of the "Global Medical Biosensors Market 2014-2018" report to their offering. Medical biosensors are used to analyze biological components with the help of physicochemical detectors. These biosensors monitor health status, disease betterment, and therapeutic treatment outcomes through invasive and non-invasive methods. They are cost-effective and user-friendly devices. Also, they are standardized to minimize errors during the diagnosis of patients. Medical biosensors are mostly used in cholesterol detection, pathogen detection, muscle displacement, and cerebrospinal detection. Medical biosensors play a major role in improving patients' quality of life. The analysts forecast the Global Medical Biosensors market to grow at a CAGR of 10.16 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Medical Biosensors market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various medical biosensors, based on their application such as: - Blood glucose testing - Cholesterol testing - Infectious disease testing - Cardiac biomarkers testing - Blood gas testing - Pregnancy testing - Others (such as cancer biomarkers, electrolyte analyzers, blood coagulation testing, tumor markers, and urinalysis testing) Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Technology 09. Market Segmentation by End-user 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape Companies Mentioned: - Abbott Laboratories - Bayer HealthCare AG - LifeScan Inc. - F. Hoffmann-La Roche Ltd. - Acethem - Acon - Biotest Medical - FICO - Contec Medical - Convergent - Integrity - I-sens - Nipro Diagnostics - Optiscan - TaiDoc - Urit Medical For more information visit http://www.researchandmarkets.com/research/lv...al_medical
UK Cardiovascular Devices Market Growth Trends, 2006 - 2019
M2 - Fri Aug 01, 2:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gkkdlp/uk_cardiovascular) has announced the addition of the "UK Cardiovascular Devices Market Growth Trends, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for UK cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 UK Market for Cardiovascular Devices (2006-2019) 5 UK Market for Cardiac Assist Devices (2006-2019) 6 UK Market for Cardiac Catheters and Guidewires (2006-2019) 7 UK Market for Cardiac Rhythm Management (2006-2019) 8 UK Market for Cardiovascular Heart Valve and Repair (2006-2019) 9 UK Market for Cardiovascular Monitoring Systems (2006-2019) 10 UK Market for Cardiovascular Surgery (2006-2019) 11 UK Market for Interventional Cardiovascular Devices (2006-2019) 12 UK Market for Peripheral Vascular Devices (2006-2019) 13 Recent Events and Developments 14 Appendix Companies Mentioned: - Abbott Laboratories - ABIOMED, Inc. - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Card Guard AG - Cardiac Science Corporation - Cordis Corporation - CryoCath Technologies Inc. - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - GE Healthcare - Invatec S.r.l. - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation For more information visit http://www.researchandmarkets.com/research/gk...iovascular
India Diabetes Management Devices Market Report, 2006 - 2019
M2 - Fri Aug 01, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2c6973/india_diabetes) has announced the addition of the "India Diabetes Management Devices Market Report, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for India diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood glucose monitoring systems and insulin delivery devices. Market Size - Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Market Growth - Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Competitive Analysis - Market share (%) of companies is covered at sector and category level for 2013. Pricing Analysis - Average selling price ($) for each product type from 2006 - 2013 and forecast till 2019. Key Topics Covered: Introduction Scope of the Report Indian Market for Diabetes Management Devices (2006-2019) Indian Market for Blood Glucose Monitoring Systems (2006-2019) Indian Market for Insulin Delivery Devices (2006-2019) Recent Events and Developments Appendix Companies Mentioned: - Abbott Laboratories - Animas Corporation - Apex Biotechnology Corp - ARKRAY, Inc. - Bayer HealthCare AG - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd - Hindustan Syringes & Medical Devices Ltd. - LifeScan, Inc. - Medtronic, Inc. - Novo Nordisk A/S - Sanofi-Aventis - Smiths Medical - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/2c...a_diabetes
UK Blood Pressure Monitors Market Opportunity and Growth Trends Forecast Till 2019
M2 - Fri Aug 01, 2:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/74jqtm/uk_blood_pressure) has announced the addition of the "UK Blood Pressure Monitors Market Opportunity and Growth Trends Forecast Till 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in the UK through 2019. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. Key Topics Covered: 1 Table of Contents 2. Introduction 3. Scope of the Report 4. UK Market for Blood Pressure Monitors, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology - Astro-Med - Bayer HealthCare - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard - Cardiac Science Corporation - Cardinal Health - Compumedics - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co - Edwards Lifesciences Corporation - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Medical Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/74...d_pressure
Tax Inversion: Boon for Firms & Investors, Bane for U.S. Treasury - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:41AM CDT
The U.S. Treasury may lose $19.5 billion over the next decade due to tax inversion.
RBCC 3D Bioprinting Partner Awarded Prestigious Grant
Business Wire - Thu Jul 31, 5:54AM CDT
The joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), moved significantly closer to its funding goals this week thanks to a prestigious research grant from the National Institutes of Health.
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 1:38PM CDT
The trend of tax inversion has been mostly prevalent in the healthcare sector. Medical devices and pharma companies are rapidly buying foreign competitors. Mutual funds holding these stocks in their portfolio should thus experience solid uplift in the near term.
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
China Blood Glucose Monitoring Systems Market, 2006 - 2019
M2 - Wed Jul 30, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7lh7q/china_blood) has announced the addition of the "China Blood Glucose Monitoring Systems Market, 2006 - 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the glucose monitoring systems in China through 2019. The product categories covered in this report include: - Traditional Glucose Monitors - Blood Glucose Test Strips The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. - Average selling price ($) for each product type (2006 to 2019). - Recent Events and Developments. Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Key Topics Covered: 1. Table of Contents 2. Introduction 3. Scope of the Report 4. Chinese Market for Blood Glucose Monitoring Systems, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - Abbott Laboratories - Apex Biotechnology Corp - Bayer HealthCare AG - F. Hoffmann-La Roche Ltd - LifeScan, Inc. - Medtronic, Inc. - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/c7...hina_blood.
Latest 13-F Filers Hold Abbott Laboratories
DividendChannel.com - Tue Jul 29, 1:10PM CDT
At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13-F filings for the 06/30/2014 reporting period, and noticed that Abbott Laboratories was held by 17 of these funds. When hedge fund managers appear to be thinking alike,...
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
Business Wire - Tue Jul 29, 7:02AM CDT
Enzo Biochem, Inc. (NYSE:ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science's U.S. Patents Nos. 6,992,180, 7,064,197, and 8,097,405. The hearing will be held in Delaware District Court. One or more of these patents is asserted against Abbott Labs, Affymetrix, Agilent, Becton Dickinson, Gen-Probe, Hologic, Illumina, Life Technologies, Luminex, Roche, and Siemens, and their related entities.
How Obama Could End Walgreen's Tax-Inversion Hopes
at Investor's Business Daily - Mon Jul 28, 1:41PM CDT
As Walgreen (WAG) mulls whether to use a loophole in U.S. tax law to save millions of dollars by moving its headquarters to Europe, a former U.S. Treasury official argued the White House could close the loophole without congressional approval. In an...
Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo
PR Newswire - Mon Jul 28, 12:00PM CDT
Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago.
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
Why Obama Has Attacked Cross-Border Mergers at This Particular Time
at The Street - Fri Jul 25, 4:39PM CDT
Obama is speaking out against corporate deserters, accusing companies of giving up their citizenship. His focus appears to be more on the election in the fall than on the economy.
Watch for Abbott Laboratories to Potentially Rebound After Falling 1.44% Yesterday
Comtex SmarTrend(R) - Tue Aug 05, 5:33PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $41.66 to a high of $42.37. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $41.81 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Roche to Acquire Santaris Pharma to Expand RNA Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 4:45PM CDT
In a bid to expand the discovery and development of RNA-targeting medicines, Roche (RHHBY) announced that it has entered into an agreement to acquire Denmark-based privately-held biopharmaceutical company Santaris Pharma.
India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019
M2 - Tue Aug 05, 5:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n5h8m7/india_patient) has announced the addition of the "India Patient Monitoring and Diagnostic Systems Market Growth Trends, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for India Patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 Indian Market for Patient Monitoring and Diagnostics (2006-2019) 5 Indian Market for Blood Pressure Monitors (2006-2019) 6 Indian Market for Cardiovascular Monitoring Systems (2006-2019) 7 Indian Market for Blood Glucose Monitoring Devices (2006-2019) 8 Indian Market for Hearing Diagnostics (2006-2019) 9 Indian Market for Micro-Electromechanical Systems(2006-2019) 10 Indian Market for Multiparameter Patient Monitors (2006-2019) 11 Indian Market for Remote Monitoring Systems (2006-2019) 12 Indian Market for Sleep Apnea Diagnostic Systems (2006-2019) 13 Indian Market for Wireless Hospital Ambulatory Monitors (2006-2019) 14 Recent Events and Developments 15 Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/n5...ia_patient
India Sleep Apnea Diagnostic Systems Market, 2006 - 2019
M2 - Tue Aug 05, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/whn3h9/india_sleep_apnea) has announced the addition of the "India Sleep Apnea Diagnostic Systems Market, 2006 - 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in India through 2019. The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. - Average selling price ($) for each product type (2006 to 2019). - Recent Events and Developments Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Key Topics Covered: 1 Table of Contents 2. Introduction 3. Scope of the Report 4. Indian Market for Sleep Apnea Diagnostic Systems, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/wh...leep_apnea
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Business Wire - Mon Aug 04, 5:30AM CDT
RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women's health, announced today the appointment of Mark Weinberg MD, MBA as Senior Vice President of Clinical Development.
Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche
M2 - Fri Aug 01, 5:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lvvzs3/global_medical) has announced the addition of the "Global Medical Biosensors Market 2014-2018" report to their offering. Medical biosensors are used to analyze biological components with the help of physicochemical detectors. These biosensors monitor health status, disease betterment, and therapeutic treatment outcomes through invasive and non-invasive methods. They are cost-effective and user-friendly devices. Also, they are standardized to minimize errors during the diagnosis of patients. Medical biosensors are mostly used in cholesterol detection, pathogen detection, muscle displacement, and cerebrospinal detection. Medical biosensors play a major role in improving patients' quality of life. The analysts forecast the Global Medical Biosensors market to grow at a CAGR of 10.16 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Medical Biosensors market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various medical biosensors, based on their application such as: - Blood glucose testing - Cholesterol testing - Infectious disease testing - Cardiac biomarkers testing - Blood gas testing - Pregnancy testing - Others (such as cancer biomarkers, electrolyte analyzers, blood coagulation testing, tumor markers, and urinalysis testing) Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Technology 09. Market Segmentation by End-user 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape Companies Mentioned: - Abbott Laboratories - Bayer HealthCare AG - LifeScan Inc. - F. Hoffmann-La Roche Ltd. - Acethem - Acon - Biotest Medical - FICO - Contec Medical - Convergent - Integrity - I-sens - Nipro Diagnostics - Optiscan - TaiDoc - Urit Medical For more information visit http://www.researchandmarkets.com/research/lv...al_medical
UK Cardiovascular Devices Market Growth Trends, 2006 - 2019
M2 - Fri Aug 01, 2:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gkkdlp/uk_cardiovascular) has announced the addition of the "UK Cardiovascular Devices Market Growth Trends, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for UK cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 UK Market for Cardiovascular Devices (2006-2019) 5 UK Market for Cardiac Assist Devices (2006-2019) 6 UK Market for Cardiac Catheters and Guidewires (2006-2019) 7 UK Market for Cardiac Rhythm Management (2006-2019) 8 UK Market for Cardiovascular Heart Valve and Repair (2006-2019) 9 UK Market for Cardiovascular Monitoring Systems (2006-2019) 10 UK Market for Cardiovascular Surgery (2006-2019) 11 UK Market for Interventional Cardiovascular Devices (2006-2019) 12 UK Market for Peripheral Vascular Devices (2006-2019) 13 Recent Events and Developments 14 Appendix Companies Mentioned: - Abbott Laboratories - ABIOMED, Inc. - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Card Guard AG - Cardiac Science Corporation - Cordis Corporation - CryoCath Technologies Inc. - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - GE Healthcare - Invatec S.r.l. - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation For more information visit http://www.researchandmarkets.com/research/gk...iovascular
India Diabetes Management Devices Market Report, 2006 - 2019
M2 - Fri Aug 01, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2c6973/india_diabetes) has announced the addition of the "India Diabetes Management Devices Market Report, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for India diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood glucose monitoring systems and insulin delivery devices. Market Size - Market size in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Market Growth - Market growth in terms of value ($) and volume (units), for each level of segmentation from 2006 to 2013 and forecast till 2019. Competitive Analysis - Market share (%) of companies is covered at sector and category level for 2013. Pricing Analysis - Average selling price ($) for each product type from 2006 - 2013 and forecast till 2019. Key Topics Covered: Introduction Scope of the Report Indian Market for Diabetes Management Devices (2006-2019) Indian Market for Blood Glucose Monitoring Systems (2006-2019) Indian Market for Insulin Delivery Devices (2006-2019) Recent Events and Developments Appendix Companies Mentioned: - Abbott Laboratories - Animas Corporation - Apex Biotechnology Corp - ARKRAY, Inc. - Bayer HealthCare AG - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd - Hindustan Syringes & Medical Devices Ltd. - LifeScan, Inc. - Medtronic, Inc. - Novo Nordisk A/S - Sanofi-Aventis - Smiths Medical - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/2c...a_diabetes
UK Blood Pressure Monitors Market Opportunity and Growth Trends Forecast Till 2019
M2 - Fri Aug 01, 2:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/74jqtm/uk_blood_pressure) has announced the addition of the "UK Blood Pressure Monitors Market Opportunity and Growth Trends Forecast Till 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in the UK through 2019. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. Key Topics Covered: 1 Table of Contents 2. Introduction 3. Scope of the Report 4. UK Market for Blood Pressure Monitors, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology - Astro-Med - Bayer HealthCare - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard - Cardiac Science Corporation - Cardinal Health - Compumedics - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co - Edwards Lifesciences Corporation - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Medical Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/74...d_pressure
Tax Inversion: Boon for Firms & Investors, Bane for U.S. Treasury - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:41AM CDT
The U.S. Treasury may lose $19.5 billion over the next decade due to tax inversion.
RBCC 3D Bioprinting Partner Awarded Prestigious Grant
Business Wire - Thu Jul 31, 5:54AM CDT
The joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), moved significantly closer to its funding goals this week thanks to a prestigious research grant from the National Institutes of Health.
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 1:38PM CDT
The trend of tax inversion has been mostly prevalent in the healthcare sector. Medical devices and pharma companies are rapidly buying foreign competitors. Mutual funds holding these stocks in their portfolio should thus experience solid uplift in the near term.
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
China Blood Glucose Monitoring Systems Market, 2006 - 2019
M2 - Wed Jul 30, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7lh7q/china_blood) has announced the addition of the "China Blood Glucose Monitoring Systems Market, 2006 - 2019" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the glucose monitoring systems in China through 2019. The product categories covered in this report include: - Traditional Glucose Monitors - Blood Glucose Test Strips The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2006 to 2019. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. - Market share of companies. - Average selling price ($) for each product type (2006 to 2019). - Recent Events and Developments. Why should you buy? - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Key Topics Covered: 1. Table of Contents 2. Introduction 3. Scope of the Report 4. Chinese Market for Blood Glucose Monitoring Systems, 2006-2019 5. Recent Events and Developments 6. Appendix Companies Mentioned: - Abbott Laboratories - Apex Biotechnology Corp - Bayer HealthCare AG - F. Hoffmann-La Roche Ltd - LifeScan, Inc. - Medtronic, Inc. - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/c7...hina_blood.
Latest 13-F Filers Hold Abbott Laboratories
DividendChannel.com - Tue Jul 29, 1:10PM CDT
At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13-F filings for the 06/30/2014 reporting period, and noticed that Abbott Laboratories was held by 17 of these funds. When hedge fund managers appear to be thinking alike,...
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
Business Wire - Tue Jul 29, 7:02AM CDT
Enzo Biochem, Inc. (NYSE:ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science's U.S. Patents Nos. 6,992,180, 7,064,197, and 8,097,405. The hearing will be held in Delaware District Court. One or more of these patents is asserted against Abbott Labs, Affymetrix, Agilent, Becton Dickinson, Gen-Probe, Hologic, Illumina, Life Technologies, Luminex, Roche, and Siemens, and their related entities.
How Obama Could End Walgreen's Tax-Inversion Hopes
at Investor's Business Daily - Mon Jul 28, 1:41PM CDT
As Walgreen (WAG) mulls whether to use a loophole in U.S. tax law to save millions of dollars by moving its headquarters to Europe, a former U.S. Treasury official argued the White House could close the loophole without congressional approval. In an...
Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo
PR Newswire - Mon Jul 28, 12:00PM CDT
Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago.
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
Why Obama Has Attacked Cross-Border Mergers at This Particular Time
at The Street - Fri Jul 25, 4:39PM CDT
Obama is speaking out against corporate deserters, accusing companies of giving up their citizenship. His focus appears to be more on the election in the fall than on the economy.
